Last quarter (Q4 2023), Belite Bio, Inc. ADR's total revenue was $―, a decrease of ― from previous quarter. In Q4, Belite Bio, Inc. ADR's net income was $―. See Belite Bio, Inc. ADR’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expense	-	$ 31.67M	$ -12.82M	$ 9.80M	$ 5.74M
Operating Income	-	$ -31.67M	$ -12.82M	$ -9.80M	$ -5.74M
Net Non Operating Interest Income Expense	-	$ 49.00K	$ 7.00K	$ 5.00K	$ -9.00K
Other Income Expense	-	$ 4.00K	$ -166.00K	$ 126.00K	-
Pretax Income	-	$ -31.62M	$ -12.65M	$ -9.67M	$ -5.75M
Tax Provision	-	$ 9.00K	-	$ 0.00	$ 1.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	-	$ -31.63M	$ -12.65M	$ -9.67M	$ -5.75M
Basic EPS	-	$ -1.19	$ -0.63	$ -0.40	$ -0.24
Diluted EPS	-	$ -1.19	$ -0.63	$ -0.40	$ -0.24
Basic Average Shares	-	$ 26.59M	$ 19.98M	$ 24.10M	$ 24.10M
Diluted Average Shares	-	$ 26.59M	$ 19.98M	$ 24.10M	$ 24.10M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	-	$ 31.67M	$ -12.82M	$ 9.80M	$ 5.74M
Net Income From Continuing And Discontinued Operation	-	$ -31.63M	$ -12.65M	$ -9.67M	$ -5.75M
Normalized Income	-	-	-	$ -9.67M	$ -5.75M
Interest Expense	-	-	-	$ 0.00	$ 21.00K
EBIT	-	-	$ -12.63M	$ -9.67M	$ -5.73M
EBITDA	-	-	$ -12.43M	$ -9.64M	$ -5.71M

Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing